Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Alexandria To Contact Him Directly To Discuss Their Options If you purchased or acquired Alexandria securities between January 27, 2025 to October 27, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bra ...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Alexandria Real Estate Equities, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AREDecember 09, 2025 6:15 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - December 9, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusiv ...

LOS ANGELES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 26, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE: ARE) securities between January 27, 2025 and October 27, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ALEXANDRIA INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTEN ...

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) primarily focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - The company reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 27-28, 2025 [6]. - Alexandria Real Estate announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the class action case, which is currently pending in the U.S. District Court for the Central District of California [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].

®™ Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Alexandria Real Estate Equities, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Alexandria Real Estate Equities securities between January 27, 2025, and October 27, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 26, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [7]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4]. Group 3: Case Background - The lawsuit alleges that defendants provided misleading information regarding Alexandria Real Estate's expected revenue and funds from operations growth for the 2025 fiscal year, particularly concerning its Long Island City property [5]. - Defendants reportedly made positive statements about the leasing value of the LIC property while concealing adverse facts, leading to investor damages when the truth was revealed [6].

SAN DIEGO, Dec. 8, 2025 /PRNewswire/ -- Company: Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a real estate investment trust (REIT) specializing in lifescience real estate with a focus on lab space, research facilities and offices for tenants in the pharmaceutical, biotech, and agricultural technology industries. What is the class period? January 27, 2025 - October 27, 2025 For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. About Robbins LLP: A ...

Lead Plaintiff Deadline is January 26, 2026 NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers of Alexandria Real Estate Equities, Inc. (NYSE: ARE) ("Alexandria") that a federal securities class action has been filed on behalf of investors who purchased Alexandria between January 27, 2025 and October 27, 2025, inclusive (the "Class Period"). Investors have until January 26, 2026 to seek appointment as lead plaintiff.  PLEASE CLICK HERE TO JOIN T ...

Core Viewpoint - Alexandria Real Estate, Inc. is facing a securities fraud class action lawsuit alleging misrepresentations regarding its Long Island City property, with a deadline for investors to act by January 26, 2026 [4][5]. Group 1: Lawsuit Details - A class action lawsuit was filed in the United States District Court for the Central District of California on behalf of investors who purchased or acquired Alexandria securities between January 27, 2025, and October 27, 2025 [4]. - The lawsuit alleges violations of the Securities Exchange Act of 1934 against Alexandria and certain senior officers due to misrepresentations about the state of its Long Island City property [4]. Group 2: Investor Participation - Investors wishing to serve as lead plaintiffs must file necessary documents by January 26, 2026, although participation as a lead plaintiff is not required to share in any potential recovery [5]. - All representation in the lawsuit is on a contingency fee basis, meaning shareholders will not incur any fees or expenses [5]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented both individual investors and large public and private pension funds [6]. - The firm has been recognized for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [6].

Core Viewpoint - Alexandria Real Estate Equities, Inc. has announced a new common stock repurchase program, replacing the previous authorization of up to $500 million, which was set to expire on December 31, 2025 [1] Group 1: Stock Repurchase Program - The new program allows the company to repurchase up to $500 million of its outstanding shares of common stock until December 31, 2026 [1] - Under the previous program, Alexandria repurchased $258.2 million of its shares primarily in January 2025 [1] - The specific timing, price, and amount of repurchases will be at the company's discretion and influenced by various factors such as stock prices and market conditions [2] Group 2: Funding and Conditions - The company prefers to fund stock repurchases on a leverage-neutral basis using net cash from operating activities after dividends and proceeds from real estate dispositions or joint ventures [2] - The stock repurchase program does not obligate the company to repurchase any specific dollar amount or number of shares and may be suspended or discontinued at any time [2] Group 3: Company Overview - Alexandria is a leading life science REIT, founded in 1994, and is recognized for its role in pioneering the life science real estate niche [3] - The company operates in key life science innovation cluster locations, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City [3]